Marc Scheineson comments on a plan by the Food and Drug Administration to prevent drug shortages by examining pharma company mergers and acquisitions.
In the News
September 11, 2018
The Pink Sheet | Could US Solve Drug Shortages with ‘Heightened’ M&A Scrutiny?
Media Contact